Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,259 | -8,281 | -16,312 | -12,036 | -10,594 |
| Depreciation Amortization | 201 | 380 | 24 | 12 | 37 |
| Income taxes - deferred | N/A | 116 | 865 | 824 | -223 |
| Accounts receivable | N/A | 229 | -614 | -121 | 4 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -23 | -1 |
| Other Working Capital | -408 | 491 | 636 | -1,614 | -86 |
| Other Operating Activity | 3,657 | 2,879 | 8,004 | 5,360 | 6,300 |
| Operating Cash Flow | $-1,809 | $-4,187 | $-7,398 | $-7,598 | $-4,564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -21 | -120 | -18 | N/A |
| Purchase Of Investment | N/A | -339 | -1,602 | -789 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 148 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -373 |
| Investing Cash Flow | $N/A | $-360 | $-1,722 | $-806 | $-225 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 30 | N/A | 350 | 4 | -381 |
| Debt Issued | 342 | 1,463 | N/A | 237 | 2,684 |
| Debt Repayment | -327 | N/A | N/A | -307 | N/A |
| Common Stock Issued | 1,342 | 3,456 | 3,664 | 11,120 | 7,615 |
| Common Stock Repurchased | -7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 601 | -1,049 | 0 | -1,058 | -350 |
| Financing Cash Flow | $1,981 | $3,870 | $4,014 | $9,996 | $9,568 |
| Exchange Rate Effect | -25 | 2 | -67 | -28 | 62 |
| Beginning Cash Position | 717 | 1,392 | 6,565 | 5,001 | 160 |
| End Cash Position | 864 | 717 | 1,392 | 6,565 | 5,001 |
| Net Cash Flow | $147 | $-675 | $-5,174 | $1,564 | $4,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,809 | -4,187 | -7,398 | -7,598 | -4,564 |
| Capital Expenditure | N/A | -21 | -120 | -18 | N/A |
| Free Cash Flow | -1,809 | -4,208 | -7,518 | -7,615 | -4,564 |